Literature DB >> 6661345

Dose-response relationships of intravenous hyoscine butylbromide and atropine sulphate on heart rate in healthy volunteers.

S L Grainger, S E Smith.   

Abstract

Heart-rate responses to intravenous hyoscine butylbromide, atropine and physiological saline in cumulative dosage regimens have been recorded in six healthy subjects. Atropine sulphate induced bradycardia at low, and tachycardia at higher, dose levels whereas hyoscine butylbromide caused only tachycardia but with a flatter dose-response relationship. Exact potency ratios could not be calculated because of the differing dose-response curves. However, an approximate estimate from a comparison of equiactive doses at the upper part of the curve yielded a value less than one half that obtained from the drugs' affinity constants in guinea-pig ileum. The findings suggest that, in addition to its action as a muscarinic antagonist, hyoscine butylbromide is a ganglion blocker in man as it is in animals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661345      PMCID: PMC1428337          DOI: 10.1111/j.1365-2125.1983.tb02231.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  COMPARISON OF HYOSCINE-N-BUTYL BROMIDE AND ATROPINE SULFATE IN MAN.

Authors:  G BROWNLEE; A B WILSON; A T BIRMINGHAM
Journal:  Clin Pharmacol Ther       Date:  1965 Mar-Apr       Impact factor: 6.875

2.  [Buscopan].

Authors:  H WICK
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1951

3.  Effects of atropine on heart-rate in healthy man.

Authors:  D A Chamberlain; P Turner; J M Sneddon
Journal:  Lancet       Date:  1967-07-01       Impact factor: 79.321

4.  The actions of atropine, tropenziline and N-butyl hyoscine bromide on the isolated distal colon of the guinea-pig: a comparison of their activities and mechanisms of action.

Authors:  S Lecchini; M Del Tacca; G Soldani; G M Frigg; A Crema
Journal:  J Pharm Pharmacol       Date:  1969-10       Impact factor: 3.765

5.  Heart rate variability in healthy subjects measured with a bedside computer-based technique.

Authors:  S E Smith; S A Smith
Journal:  Clin Sci (Lond)       Date:  1981-10       Impact factor: 6.124

6.  A model of two functionally antagonistic receptor populations activated by the same agonist.

Authors:  E Szabadi
Journal:  J Theor Biol       Date:  1977-11-07       Impact factor: 2.691

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
  7 in total
  6 in total

1.  Cardiovascular effects of hyoscine butylbromide in pediatric halothane anesthesia.

Authors:  M Yamashita; K Tajima
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

2.  Does nasal oxygen reduce the cardiorespiratory problems experienced by elderly patients undergoing endoscopic retrograde cholangiopancreatography?

Authors:  D J Haines; D Bibbey; J R Green
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  Hyoscine for polyp detection during colonoscopy: A meta-analysis and systematic review.

Authors:  Imran Ashraf; Sohail Ashraf; Sameer Siddique; Douglas L Nguyen; Abhishek Choudhary; Matthew L Bechtold
Journal:  World J Gastrointest Endosc       Date:  2014-11-16

4.  The elimination of treatment predictability in double-blind studies.

Authors:  A L Jones; S L Grainger; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

5.  Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects.

Authors:  P Danjou; P Molinier; I Berlin; A Patat; P Rosenzweig; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

6.  Anesthetic management of peroral endoscopic myotomy for esophageal achalasia: a retrospective case series.

Authors:  Eriko Tanaka; Hiroaki Murata; Hitomi Minami; Koji Sumikawa
Journal:  J Anesth       Date:  2013-11-02       Impact factor: 2.078

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.